Front. Cell. Infect. Microbiol. Frontiers in Cellular and Infection Microbiology Front. Cell. Infect. Microbiol. 2235-2988 Frontiers Media S.A. 10.3389/fcimb.2022.1045109 Cellular and Infection Microbiology Original Research Maternal gestational Bifidobacterium bifidum TMC3115 treatment shapes construction of offspring gut microbiota and development of immune system and induces immune tolerance to food allergen Cheng Ruyue 1 Zhang Yujie 1 Yang Yang 1 Ren Lei 2 Li Jinxing 1 Wang Yimei 1 Shen Xi 1 * He Fang 1 * 1 Department of Nutrition and Food Hygiene, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China 2 Department of Research and Development, Hebei Inatural Bio-tech Co., Ltd, Shijiazhuang, Hebei, China

Edited by: Carla R. Taddei, University of São Paulo, Brazil

Reviewed by: Ravichandra Vemuri, Wake Forest Baptist Medical Center, United States; Ruijie Huang, Sichuan University, China; Yujun Wu, China Agricultural University, China

*Correspondence: Fang He, hf18602880124@163.com; Xi Shen, hxgwshenxi@sina.com

This article was submitted to Intestinal Microbiome, a section of the journal Frontiers in Cellular and Infection Microbiology

14 11 2022 2022 12 1045109 15 09 2022 24 10 2022 Copyright © 2022 Cheng, Zhang, Yang, Ren, Li, Wang, Shen and He 2022 Cheng, Zhang, Yang, Ren, Li, Wang, Shen and He

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

In this study we aimed to determine whether treatment with maternal Bifidobacterium bifidum TMC3115 could affect the composition of the gut microbiota and the development of the immune system and intestinal tract of offspring, and protect the offspring from IgE-mediated allergic disease. Pregnant BALB/c mice were gavaged with TMC3115 until delivery. Offspring were sensitized with ovalbumin from postnatal days 21 to 49. After maternal treatment with TMC3115, the microbiota of the offspring’s feces, intestinal contents, and stomach contents (a proxy for breast milk) at the newborn and weaning stages exhibited the most change, and levels of immunoglobulin in the sera and stomach contents and of splenic cytokines, as well as the mRNA levels of colonic intestinal development indicators were all significantly altered in offspring at different stages. After sensitization with ovalbumin, there were no significant changes in the levels of serum IgE or ovalbumin-specific IgE/IgG1 in the TMC3115 group; however, IgM, the expression of intestinal development indicators, and the production of fecal short chain fatty acid (SCFA) were significantly increased, as were the relative abundances of Lactobacillus and the Lachnospiraceae NK4A136 group. Our results suggested that maternal treatment with TMC3115 could have a profound modulatory effect on the composition of the gut microbiota and the development of the immune system and intestinal tissue in offspring at different stages of development, and may induce immune tolerance to allergens in ovalbumin-stimulated offspring by modulating the gut microbiota and SCFA production.

allergy Bifidobacterium gut microbiota immune function SCFA

香京julia种子在线播放

    1. <form id=HxFbUHhlv><nobr id=HxFbUHhlv></nobr></form>
      <address id=HxFbUHhlv><nobr id=HxFbUHhlv><nobr id=HxFbUHhlv></nobr></nobr></address>

      Introduction

      In recent years, the incidence of allergic diseases such as asthma, allergic rhinitis, and food allergies has been increasing in both developed and developing countries, including China (Platts-Mills, 2015). Allergic disease is a dynamic lifelong process and there is no cure at present; therefore, early prevention is particularly important. In 1989, Strachan proposed the “Hygiene hypothesis” which holds that a lack of exposure to environmental microbes in the early stages of life restricts the development and maturation of the body’s immune system, thereby increasing the risk of allergic diseases in childhood (Strachan, 1989). Evidence has since accumulated, demonstrating that the gut microbiota in early life may be a novel target for the early prevention and treatment of allergic diseases (Gensollen and Blumberg, 2017).

      The period from conception to the age of two is considered to be critical for the development of the gut microbiota and the development of the immune system (Arrieta et al., 2014). Researchers have long believed that the fetus is sterile in the uterus, and that microbes first colonize the infant intestine after birth. However, current population and animal experimental studies have suggested that the first microbial exposure of newborns may occur before birth, and this exposure may have a regulatory effect on the development of the newborn’s immune system (Collado et al., 2016; Gomez de Agüero et al., 2016). Our previous study found microorganisms in the placenta and cultured live bacteria from the blood of the newborn mice and the placenta, further verifying that microbial contact with the newborn might exist before birth (Cheng et al., 2021). The maternal microbiota is considered to be the largest source of the gut microbiota of newborns, whereas the microbes of the vagina, skin, and oral cavity account for only a small proportion of the newborn gut microbiota, suggesting that the maternal microbiota has an important effect on the early gut microbiota of the offspring (Shao et al., 2019). Therefore, paying attention to the changes of the maternal microbiota during pregnancy before birth, using approaches such as probiotic intervention, is important to the development of the infant gut microbiota and immune system, and subsequent susceptibility to allergic diseases in later life.

      Probiotics regulate the structure of the gut microbiota by promoting the growth of beneficial microorganisms in the intestine. Meta-analysis based on a randomized controlled double-blind trial (RCT) study suggests that the use of probiotics by mothers during pregnancy and lactation may reduce the risk of atopic dermatitis in their offspring; however, these results have a certain population heterogeneity and strain specificity (Li et al., 2019; Amalia et al., 2020), suggesting that it is necessary to explore the early preventive effect of probiotics on allergic diseases at the strain level. Bifidobacterium, one of the most widely studied and used probiotics, is one of the first microorganisms to colonize the human intestine, and several species, including B. breve and B. bifidum, are considered to be permanent residents. B. bifidum TMC3115 (TMC3115) is a probiotic strain isolated from the intestines of healthy infants (He et al., 2001). Whole genome sequencing shows that TMC3115 encodes enzymes that decompose host-derived breast milk polysaccharides (HMOs), mucins, and plant-derived polysaccharides. The complex polysaccharides that cannot be digested and absorbed by the host cells are decomposed into monosaccharides or disaccharides in the way of “Cross Feeding”, and are then provided to other bifidobacteria or intestinal bacteria, promoting symbiosis of the gut microbiota and the host (Gotoh et al., 2018). Our previous study found that supplementation with the probiotic strain TMC3115 from birth to weaning can reduce the risk of the host suffering from IgE-mediated allergic diseases in adulthood, by regulating the composition of the gut microbiota, increasing short chain fatty acid (SCFA) production, and promoting the immune system and intestinal tissue development of the host (Cheng et al., 2019). An RCT study found that TMC3115 could alleviate allergic symptoms and inflammatory responses and affect the gut microbiota composition of neonates aged 0–1 years who were allergic to cow milk proteins (Jing et al., 2020). However, the question of whether supplementation with TMC3115 during pregnancy can still exert a protective effect, and the mechanisms underlying such an effect, need further research.

      In this study we explored the effects of exposure to TMC3115 during pregnancy on the maternal microbiota, and the role of the maternal microbiota in the composition of the gut microbiota of the offspring, the development of their immune system and intestinal tract, and their susceptibility to IgE-mediated allergic diseases, and we further investigated the mechanisms underlying these effects.

      Methods Probiotic treatment

      TMC3115 was kindly provided by Hebei Inatural Biotech Co. Ltd. (Hebei, PR China). Freeze-dried living TMC3115 (2.12 × 1011 colony-forming unit [CFU]/g) was dissolved in sterile saline to prepare bacterial suspensions of 5 × 109 CFU/mL. The daily intake of living TMC3115 was estimated as 109 CFU/mouse, 0.2 mL/d, once a day.

      Animals

      Fourteen pregnant specific pathogen-free BALB/c mice at gestational day 10–13 (Approval number: SCXK2015-0001) were purchased from Liaoning Changsheng Biotechnology Co., Ltd (Liaoning, PR. China), and kept in individually ventilated plastic cages at an ambient temperature of 23°C ± 1°C and humidity of 50%–70% under a 12 h light/dark cycle with free access to water and food.

      The study design is shown in Figure 1A . Pregnant mice were randomly divided into two groups: a Control group and a TMC3115 group (n = 7 per group). Mice in the Control group were gavaged with saline from 1 week before and until delivery, while mice in the TMC3115 group were gavaged with a TMC3115 suspension. The organs, feces, vaginal douches, and blood of dams were collected at and after delivery day (ADD) 0 and 21, and a proportion of pups at postnatal day (PND) 0, 7, 14, and 21 were euthanized to collect blood, stomach contents (PND 0, 7, and 14), spleen, intestinal contents (PND 0, 7, and 14), colon and feces (PND 21). Then, half of the remaining pups in the two groups were intraperitoneally sensitized with ovalbumin (OVA) while the other half of the pups were not injected with any substance. All the remaining pups were sacrificed at PND49, and their organs, blood, and feces were collected.

      Study design and immunoglobulins of stomach contents of offspring from PND 0–14. (A) Experimental design. Sample sizes for microbiota analysis are clarified in the corresponding legends. (B–I) IgG and subclass, IgM, IgA, and sIgA levels of stomach contents of offspring from PND 0–14. *: P < 0.05, **: P < 0.01, ****: P < 0.0001, compared with Control. PND, postnatal day. n = 10/group.

      Sample collection

      Feces of dams were collected at ADD 0 and 21 and pups at PND 21 and 49. Plastic boxes were wiped with 75% ethanol, the mice were placed into these boxes, and more than 200 mg of naturally excreted feces were collected from each mouse within several hours.

      Vaginal douches and blood of dams at ADD 0 were collected within 12 hours after the dams gave birth. Dams were placed into a 50 mL centrifuge tube, and their tails were exposed to the outside of the centrifuge tube and secured with tape. Then, the skin near the vagina and the tails of dams were wiped twice with 75% ethanol, with the dams ventral side up. A pipette was used to aspirate 50 μL of sterile saline, and the tip was carefully inserted into one side of the dams’ vagina, and then pipetting was repeated several times, avoiding saline leakage and contamination, and then the rinsing fluid was sucked out and placed in a 1.5 mL centrifuge tube. Vaginal douches were collected from the other side of the dams’ vaginas using the same method. A sterile surgical blade was used to make a small incision 2–3cm from the base of the tail, and 100 μL of blood was collected in a 1.5 mL centrifuge tube. Finally, a cotton ball was pressed on the wound for two minutes to stop the bleeding and keep the dams alive.

      The blood of dams at ADD 21 and of pups at PND 21 and PND 49 were collected by removing the eyeballs after the mice were euthanized by inhalation of carbon dioxide. The blood of pups at PND 0, 7, and 14 was collected by beheading after they were euthanized by inhalation of carbon dioxide. The colon and spleen of mice were collected under sterile conditions after the mice were sacrificed.

      The stomach and intestinal contents of pups were collected under sterile conditions at PND 0, 7, and 14, after the pups were sacrificed. The stomach contents were considered to be a proxy for breast milk (Nyangahu et al., 2018), because it was difficult to collect milk from the nipples of the dams, while avoiding contamination. The intestinal contents was considered to be a proxy for feces, because the pups were too young for the collection of. Briefly, the whole stomach was collected using sterile scissors and tissue forceps, and placed into a sterile 1.5 mL centrifuge tube. Then, the stomach tissue was bluntly dissected using tissue forceps, and the stomach contents of the pups were left in the tubes. The whole intestine of pups were collected under sterile conditions and placed in a sterile plastic plate. The intestinal contents were expelled from the intestinal lumen using a sterile curved forceps along the entire intestinal tract. Two hundred microliters of sterile PBS was added to the plate, and the viscous intestinal contents were collected by repeatedly pipetting and rinsing with a pipette. The resulting mixture was placed into a 1.5 mL centrifuge tube. The collected intestinal contents mixture actually contained the contents in the small intestine and colon, thus the microbiota found in the intestinal contents was named as small intestinal and colonic microbiota in the following text.

      OVA sensitization

      The OVA sensitization procedure was performed as previously described, with some modifications (Cheng et al., 2019). Briefly, pups were injected intraperitoneally with 40 μg of OVA and 4 mg of Imject Alum (Sigma-Aldrich, St. Louis, MO, USA) suspension on PND 21, 35, and 42.

      Total RNA extraction from animal tissue and quantitative reverse transcription-polymerase chain reaction

      Total RNA was extracted from spleen and colon using a commercial kit (Foregene, Chengdu, PR. China) in accordance with the manufacturer’s instructions. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) was performed as previously described, with minor modifications (Cheng et al., 2020). Briefly, complementary DNA (cDNA) was synthesized using iScript™ cDNA synthesis kits (Bio-Rad, Hercules, CA, USA), and the quantification of cDNA was performed using SsoAdvanced™ Universal SYBR® Green Supermix (Bio-Rad). The quantitative PCR reaction system consisted of 5 μL of 1x SsoAdvanced™ Supermix, 0.5 μL of 100 μM forward primer, 0.5 μL of 100 μM reverse primer, 1 μL of cDNA (100 ng to 100 fg), and 3 μL of double-distilled water (ddH2O). The cycling conditions were as follows: initial denaturation at 98°C for 30 s, followed by 40 cycles of denaturation at 98°C for 15 s, and annealing/extension at 60°C for 30 s. β-actin was used as the reference gene, and 2−△△ct calculation was used to determine the relative levels of the mRNA of the targeted gene. Primer sequences are listed in Table S1 . All primers were synthesized by Shanghai Sangon Biotech Co., Ltd. (Shanghai, China PR).

      Hematoxylin-eosin staining

      Colons were collected from pups at PND 21. One centimeter of each sample was cut and fixed with 10% neutral phosphate-buffered saline formalin for 24 h, and then stained with hematoxylin-eosin (HE). Optical microscopic images were inspected by a pathologist blinded to the experimental design. As previously described (Cheng et al., 2017), an optical microscope (Olympus Corporation, Tokyo, Japan) was used to image the intestinal tissues. The fields of view were randomly selected, and included non-necrosis, hemorrhage, and non-specific staining marginal areas. A charged coupled device was used to collect high-quality images. Ten areas were measured from each of the upper, lower, left, right, and middle of each slice, and the parameters of 50 colonic crypts in total on each slice were measured.

      Enzyme-linked immunosorbent assay

      The levels of IgG, IgM, IgA, sIgA, IgG1, IgG2a, IgG2b, and IgG3 in serum and the supernatant of stomach contents, and sIgA from the supernatants of feces and intestinal contents were detected using enzyme-linked immunosorbent assay (ELISA) with commercial kits (Elabscience, Wuhan, PR. China). Aliquots of 10 mg of stomach contents were added to 90 μL of sterile PBS and centrifuged for 3 min at 6000 g to obtain supernatants. Feces (50 mg) were mixed with 200 μL of sterile PBS, vortexed, and then centrifuged for 3 min at 6000 g to obtain supernatants. Serum IgE was determined via ELISA using mouse IgE ELISA kits (Invitrogen, Thermo Fisher Scientific, Inc., MA, USA). Serum OVA-specific IgE and IgG1 were detected using Anti-Ovalbumin IgE (mouse) ELISA kits and IgG1 (mouse) ELISA kits (Cayman Chemical, MI, USA). The serum cytokines IL-1β, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-13, IL-17A, and IFN-γ were measured using Luminex (R&D Systems Inc., MN, USA). Assays were performed according to the manufacturer’s instructions and read using a Multiskan™ GO microplate spectrophotometer (Thermo Fisher Scientific, Inc., MA, USA) and a Luminex 200™ multiplexing instrument (Merck Millipore, MA, USA).

      DNA extraction from intestinal contents, feces, vaginal douches and stomach contents

      Total DNA was extracted from mouse intestinal contents and feces (100 mg) of offspring at PND 0, 7, 14, 21, and 49, maternal feces at ADD 0 and 21, stomach contents at PND 0, 7, and 14, and maternal vaginal douches at ADD 0, using the TIANamp Stool DNA Kit (Tiangen Biotech Co. Ltd., Beijing, PR China) in accordance with the manufacturer’s instructions.

      Amplification and sequencing of 16S rRNA encoding gene sequences

      The 5’ ends of the primers were tagged with barcodes specific to each sample and sequencing universal primers. PCR amplification was performed in a total volume of 25 μL of reaction mixture containing 50 ng of DNA, 12.5 μL of Phusion Hot start flex 2X Master Mix (NEB, M0536L), 2.5 μL of each of forward primer 338F 5’-ACTCCTACGGGAGGCAGCAG-3’ and reverse primer 806R 5’-GGACTACHVGGGTWTCTAAT-3’ (16S V3-V4 primer), and ddH2O was used to adjust the volume. The PCR conditions were 98°C for 30 s, followed by 35 cycles of 98°C for 10 s, 54°C for 30 s, and 72°C for 45 s, and then 72°C for 10 min. The PCR products were separated using 2% agarose gel electrophoresis, purified with AMPure XT beads (Beckman Coulter Genomics, Danvers, MA, USA), and then quantified using a Qubit (Invitrogen, USA). Amplicon pools were prepared for sequencing, and the size and quantity of the amplicon library were assessed using an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) and the Library Quantification Kit for Illumina (Kapa Biosciences, Woburn, MA, USA), respectively. A PhiX Control library (v3) (Illumina) was combined with the amplicon library (expected at 30%). The libraries were sequenced on an Illumina MiSeq Instrument (Illumina Inc., San Diego, CA, USA) using the 300-base pair (bp) paired-end protocol with the standard Illumina sequencing primers.

      Bioinformatics

      Briefly, raw FASTQ files were generated using Illumina’s bcl2fastq (v1.8.4) software. Trimmomatic (v0.36) was used to remove the barcode and primer sequences, and paired-end reads were then merged using FLASH (v1.2.11). The two-terminal valid and high-quality sequences were then spliced using the QIIME2-DADA2 process, which required sequence overlap of at least 10 bp and allowed a maximum of two base mismatches. The Amplicon Sequence Variants (ASVs) were constructed and taxonomic assignment was performed based on the SILVA Living Tree Project v138 (LTPv138) database (16S V3-4). Multiple sequences were aligned and a phylogenetic tree was constructed. The phylogenetic tree, ASVs abundance table, alpha diversity (ACE, Chao1, observed features, Shannon, Simpson), and beta diversity (Bray–Curtis, weighted and unweighted UniFrac) were calculated using QIIME2. The pairwise difference between the mean values species richness and the diversity index was measured using the Wilcox test (R program). Microbiota community composition was shown at phylum and genus level. All plots were visualized within the R program (v3.4.1).

      Detection of fecal SCFA

      Fecal SCFA (acetic, propionic, and butyric acid) were detected using gas chromatography. Feces (100 mg) were mixed with 400 μL of ether, 100 μL of internal standard (4-methyl valeric acid), and 100 μL of 15% phosphoric acid, vortexed, and then centrifuged for 10 min at 4°C at 13400 g. Sample supernatant (1 μL) was analyzed using an Agilent 7890A (Agilent Technologies, Inc.).

      Statistical analysis

      Statistical analysis was performed using GraphPad Prism 8.0.1 (GraphPad Software, San Diego, California USA, www.graphpad.com). Data are expressed as the mean ± standard error of the mean. Student’s t-tests or Mann–Whitney U tests were used for pairwise comparisons. A probability (P) value < 0.05 was considered significant. All statistical tests were two-tailed.

      Results Effect of TMC3115 on maternal immune function, vaginal and fecal microbiota, and SCFA production

      After delivery day 0, there was a significant decrease in the levels of serum IgG1, IgG3, and fecal sIgA in dams treated with TMC3115 in comparison with those in the Control group, while the levels of serum IgM tended to decrease ( Figure S1 ). After delivery day 21, the levels of serum immunoglobulin and fecal sIgA of dams treated with TMC3115 were similar to those of the Control group ( Figure S2A ). However, compared with those in the Control group, the mRNA expression of splenic IL-8, IL-10, and IL-17A in dams treated with TMC3115 was significantly increased; moreover, the expression of TNF-α and TGF-β1 showed a tendency to be increased ( Figures S2B–H ).

      After delivery day 0, the alpha diversity of dams treated with TMC3115 did not significantly change in comparison with that of the Control ( Figure S3A ). However, the fecal microbiota community was altered to some extent, and Principal Coordinates Analysis (PCoA) analysis showed two clear clusters ( Figures S3B–D ). At the phylum and genus level, the relative abundances of Proteobacteria, Deferribacteres, Helicobacter, Mucispirillum, and Prevotella in the TMC3115 group were significantly lower than those in the Control group, while the relative abundance of Rikenella in the TMC3115 group was significantly higher ( Table S2 ). The level of fecal acetic acid from dams treated with TMC3115 was significantly decreased compared with that in the Control group ( Figure S3E ).

      After delivery day 21, the Simpson index of the TMC3115-treated group was significantly lower than that of the Control group, while the Shannon index of the TMC3115-treated group tended to decrease ( Figure S3F ). The fecal microbiota composition was altered by TMC3115 treatment during pregnancy, as demonstrated by significantly decreased abundance of Alistipes and increased abundances of Lactobacillus, Roseburia, and Staphylococcus; PCoA also showed two clusters separated by the axis, with several overlapping areas ( Figures S3G–I and Table S2 ). The fecal acetic and propionic acid levels in the TMC3115-treated group were significantly lower than those in the Control group ( Figure S3J ).

      On the day after dams gave birth, vaginal douches were collected and sequenced to observe changes to the vaginal microbiota. The ACE, Chao1, and observed OTUs of the TMC3115 group were significantly lower than those of the Control group, while the Shannon and Simpson indexes also tended to decrease ( Figure S4A ). The Bray–Curtis distance was used to compare the beta diversity between groups, and two clusters were separated using PCoA analysis ( Figure S4B ). At the phylum level, the relative abundances of Firmicutes and Desulfobacterota in the TMC3115 group were significantly decreased, while the abundance of Proteobacteria was significantly increased when compared with those of the Control group ( Figure S4C and Table S2 ). At the genus level, the relative abundances of Oscillibacter A2, Lachnospiraceae UCG.006, Clostridia vadin BB60 group, Desulfovibrio, Lachnospiraceae NK4A136 group, Citrobacter undefined, Lachnospiraceae, and Lactobacillus in the TMC3115 group were significantly decreased when compared with those in the Control group; however, the abundances of Escherichia, Shigella, Bifidobacterium, and Psychrobacter were significantly increased ( Figure S4D and Table S2 ).

      Alterations to immunoglobulin and the microbiota of the stomach contents

      Between PND 0 and PND 14, the level of IgG and associated subclasses, and the IgM level in stomach contents gradually decreased, while the levels of IgA and sIgA gradually increased ( Figures 1B–I ). At PND 0, the IgG content of the stomach contents in the TMC3115 group was significantly higher than that in the Control group ( Figure 1B ). The IgG2a content at PND 7 and PND 14, and the IgM content at PND 14 in the TMC3115 group were significantly lower than those in the Control group ( Figures 1C, G ). The IgA and sIgA contents at PND 14 in the TMC3115 group tended to be lower than those in the Control group ( Figures 1D, E ).

      In the Control group, the alpha diversity at PND 0 was significantly higher than those at PND 7 and PND 14 ( Figure 2A ). Similarly, in the TMC3115 group, the alpha diversity, including ACE, Chao1, observed OTUs, and Shannon index at PND 0 were significantly higher than those at PND 7; the Shannon index at PND 14 was also significantly higher than that at PND 7 ( Figure 2B ). At PND 0 and PND 7, the Shannon and Simpson indexes of the TMC3115 group were significantly lower than those of the Control group; however, there were no significant differences in alpha diversity at PND 14 between the groups ( Figure 2C ).

      Diversity and composition of stomach content microbiota of offspring from PND 0–14. (A, B) Changes of alpha diversity of the microbiota of the stomach contents of offspring from PND 0–14 in two groups. (C) Differences of alpha diversity between groups. (D, E) Microbial community of the stomach contents of offspring at phylum and genus levels. (F) Significantly altered bacteria between groups. (h) PCoA analysis based on Bray-Curtis distance. *: P < 0.05, **: P < 0.01, ****: P < 0.0001, compared with Control. PND, postnatal day. n = 6/group.

      At PND 0, Firmicutes, Actinobacteriota, and Proteobacteria were the three predominate phyla, and Lactobacillus, Staphylococcus, Streptococcus, and Corynebacterium were the four predominate genera in the stomach contents. However, the relative abundances of Actinobacteriota, Staphylococcus, Streptococcus, and Corynebacterium gradually decreased, while the relative abundances of Firmicutes and Lactobacillus largely increased. Therefore, Firmicutes and Proteobacteria became the predominate phyla and Lactobacillus became the only predominate genus in stomach contents at PND 7 and PND 14 ( Figures 2D, E ). Only the abundances of Bacteroidota and Lactobacillus in the TMC3115 group at PND 0 were significantly lower than those in the Control group ( Figure 2F ). No significant differences in abundance were found between the groups at PND 7 and PND 14. Consistently, PCoA analysis indicated that the microbiota community was similar at PND 7 and PND 14 between the Control and TMC3115 groups, which were gathered into one cluster but clearly separated from samples at PND 0. The samples in the Control and TMC3115 groups were gathered into two clusters with several overlapping areas ( Figure 2G ).

      Alterations to immune function, intestinal epithelial cells, and barrier function development of offspring

      The levels of serum immunoglobulin and fecal sIgA dynamically changed with age. At PND 0, the serum IgG and sIgA levels in the TMC3115-treated group were significantly higher than those in the Control group, while the IgG3 levels were lower than those in the Control group ( Figures 3A, E, I ).

      Levels of serum immunoglobulins and cytokines, mRNA expression of splenic cytokines, and intestinal tissue development of offspring from PND 0–49. (A–J) Significant changes in serum immunoglobulins and fecal sIgA levels of offspring from PND 0–49 between two groups. (K–L) Significant changes in splenic cytokines and colonic occludin mRNA expression of offspring at PND 7 between two groups. (M, O) Significant changes in splenic cytokines mRNA expression of offspring at PND 14 between two groups. (N–P) Significant changes in colonic Ki67, occludin mRNA expression, and colonic depth of offspring at PND 21 between two groups. (Q–V) Significant changes in splenic cytokines, mRNA expression of transcriptional factors, and serum cytokines of offspring at PND 49 between two groups. *: P < 0.05, **: P < 0.01, ***: P < 0.001, ****: P < 0.0001, compared with Control. PND, postnatal day. n = 9–12/group.

      At PND 7, the levels of serum IgG3 in the TMC3115 group were significantly higher than those in the Control group while those of IgE and IgG2b only tended to be higher ( Figures 3C, H, I ). Compared with that in the Control group, the level of mRNA of splenic TGF-β1 was significantly decreased, and the mRNA level of colonic occludin was significantly increased ( Figures 3K, L ).

      At PND 14, the levels of serum IgE and IgG2b in the TMC3115 group tended to be lower, while that of sIgA tended to be higher than those in the Control group ( Figures 3C, E, H ). The mRNA expression of splenic IL-17A tended to decrease when compared with that of the Control group ( Figure 3M ).

      At PND 21, the levels of serum IgG and IgE and fecal sIgA in the TMC3115 group were significantly lower than those in the Control group, while the levels of serum IgG1 levels tended to be higher ( Figures 3A, C, F, J ). Colonic Ki67 and occludin mRNA expression and the colonic depth were significantly increased compared with those in the Control group ( Figures 3N–P ).

      At PND 49, the levels of serum IgG, IgM, IgA, sIgA, IgG2a, IgG2b, and IgG3 in the TMC3115 group were significantly lower, and levels of serum IgE and fecal sIgA were significantly higher than those in the Control group ( Figures 3A–J ). The splenic mRNA expression of IL-10, IL-17A, and ROR-γt, and levels of serum IL-10 and IL-17A in the TMC3115 group were significantly increased compared with those in the Control group, while the splenic GATA-3 mRNA expression in the TMC3115 group tended to be increased ( Figures 3Q–V ).

      Alterations of fecal, small intestinal, and colonic microbial composition and SCFA production of offspring

      In the Control group, the alpha diversity (including ACE, Chao1, Observed OTUs, Shannon, and Simpson index) gradually but significantly increased with age. However, at PND 7, the alpha diversity was the lowest among the time points, and the Shannon index was significantly lower than at other time points ( Figure 4A ). Similarly, in the TMC3115 group, the alpha diversity gradually but significantly increased with age ( Figure 4B ). There were no significant differences found in alpha diversity between groups at any of the time points, although the Shannon index in the TMC3115 group tended to be lower than that in the Control group ( Figure 4C ).

      Diversity and composition of the fecal, small intestinal and colonic microbiota of offspring from PND 0–49. (A, B) Changes of alpha diversity of fecal, small intestinal and colonic microbiota of offspring from PND 0–49 in two groups. (C) Differences of alpha diversity of the fecal, small intestinal and colonic microbiota of offspring between groups. (D, E) Fecal, small intestinal and colonic microbial community of offspring at phylum and genus levels. (F) PCoA analysis based on Bray-Curtis distance. (G, H) Fecal SCFA production of offspring at PND 21 and PND 49. *: P < 0.05, **: P < 0.01, ***: P < 0.001, ****: P < 0.0001, compared with Control. PND: postnatal day. AA, acetic acid; PA, propionic acid; BA, butyric acid. PND 0, Control group, n = 4, TMC3115 group, n = 2; PND 7 and PND 14, n = 6/group; PND 21, n = 7/group; PND 49, n = 6/group.

      In the Control group at PND 0, the phyla predominating in the small intestinal and colonic microbiota were Proteobacteria, Firmicutes, and Actinobacteriota, while the predominate genera were Lactobacillus, Corynebacterium, Streptococcus, and Ammoniphilus. In the TMC3115-treated group, the two phyla predominating the small intestinal and colonic microbiota were Proteobacteria and Firmicutes, while Acinetobacter and Rodentibacter were the two predominate genera ( Figures 4D, E ). With age, the relative abundances of Proteobacteria and Actinobacteriota gradually decreased, while the abundance of Bacteroidota gradually increased in the two groups. The relative abundances of the predominate genera at PND 0 gradually decreased, and several newly colonized genera predominated with increasing age. At PND 7, the two predominate phyla in both groups were Proteobacteria and Firmicutes, while the three predominate genera were Lactobacillus, Escherichia-Shigella, and Rodentibacter. At PND 14, the phyla Bacteroidota, Proteobacteria, and Firmicutes and genera Lactobacillus, Escherichia-Shigella, and Bacteroides predominated in both groups. At PND 21 and 49, the phyla Bacteroidota and Firmicutes and genera Lactobacillus, Muribaculaceae, and Lachnospiraceae NK4A136 group were predominate in both groups.

      At PND 0, the relative abundances of Proteobacteria, Acinetobacter, and Rodentibacter in the TMC3115 group were significantly increased compared with those in the Control group, whereas those of Firmicutes, Bacteroidota, Lactobacillus, Corynebacterium, and Staphylococcus were significantly decreased, and the abundances of Actinobacteriota and Streptococcus were slightly decreased. At PND 21, the relative abundances of Patescibacteria and Prevotellaceae UCG.001 were significantly decreased, and those of Bacteroidota, Alistipes, and Muribaculaceae tended to be decreased, whereas the relative abundances of Firmicutes, Desulfobacterota, Lactobacillus, and Enterorhabdus tended to be increased. At PND 49, the relative abundances of Actinobacteriota, Bacteroidota, Rikenellaceae RC9 gut group, Clostridia UCG 014, and Muribaculaceae were significantly increased, whereas those of Desulfobacterota, Firmicutes, undefined Lachnospiraceae, Lachnospiraceae NK4A136 group, Eubacterium siraeum group, and Colidextribacter were significantly decreased ( Table 1 ).

      Mean relative abundance of microbiota in feces and intestinal contents of offspring from PND 0-49 at phylum and genus level (%).

      Stage Phylum/Genus Control TMC3115
      PND0 Proteobacteria 13.44 89.74***
      Firmicutes 66.65 9.43**
      Bacteroidota 0.46 0.04*
      Actinobacteriota 19.14 0.55 (P = 0.071)
      PND0 Lactobacillus 18.11 2.46*
      Staphylococcus 5.43 0.49*
      Corynebacterium 18.96 0.38 (P = 0.072)
      Streptococcus 25.22 5.38 (P = 0.072)
      PND21 Patescibacteria 0.33 0.10*
      Firmicutes 54.93 72.95 (P = 0.054)
      Bacteroidota 42.87 24.84 (P = 0.056)
      Desulfobacterota 0.23 0.53 (P = 0.078)
      PND21 Prevotellaceae.UCG.001 1.16 0.15*
      Lactobacillus 38.34 51.80 (P = 0.071)
      Alistipes 1.77 1.07 (P = 0.084)
      Enterorhabdus 0.23 0.48 (P = 0.092)
      Muribaculaceae 30.17 19.60 (P = 0.093)
      PND49 Actinobacteriota 0.43 0.84**
      Bacteroidota 45.10 62.65*
      Desulfobacterota 3.25 0.70*
      Firmicutes 49.02 34.99*
      PND49 Undefined.Lachnospiraceae 3.06 1.07**
      Lachnospiraceae.NK4A136.group 20.42 4.72**
      Rikenellaceae.RC9.gut.group 0.28 1.28**
      Eubacterium.siraeum.group 1.30 0.34**
      Clostridia.UCG.014 1.07 2.66*
      Muribaculaceae 27.20 42.77*
      Colidextribacter 1.65 0.94*

      PND, postnatal day; *: compared with Control, P < 0.05; **: compared with Control, P < 0.01. ***: compared with Control, P < 0.001. Welch’s T test was used for pairwise comparison. PND0, Control group, n = 4, TMC3115 group, n = 2; PND21, n = 7/group; PND49, n = 6/group.

      There were four clusters separated via PCoA analysis based on Bray–Curtis distance. These groups included samples taken at PND 0, 7, 14, 21, and 49. Samples in the two groups at PND 0 and PND 49 were clearly separated, while samples in the two groups at PND 7, 14, and 21 overlapped ( Figure 4F ). The levels of fecal acetic and propionic acid at PND 21 and of propionic acid at PND 49 in the TMC3115 group were significantly lower than those in the Control group ( Figures 4G, H ).

      Susceptibility and immune response to IgE-mediated allergic disease and intestinal development of offspring

      After sensitization by OVA, there were no significant changes in the levels of serum IgE and OVA-specific IgE of offspring at PND 49 in the TMC3115 group compared with the Control group ( Figures 5A, B ). However, the levels of serum OVA-specific IgG1 in the TMC3115 group tended to be decreased in comparison with those in the Control group ( Figure 5C ). Moreover, the level of serum IgM in the TMC3115 group was significantly higher than that in the Control group, while that of serum sIgA also tended to be higher ( Figures 5D, E ). The colonic mRNA expression of Ki67, Muc2, ZO-1, claudin-1, claudin-2, and occludin in the TMC3115 group was significantly higher than that in the Control group ( Figures 5F–K ).

      Serum immunoglobulins, mRNA expression of splenic cytokines, and intestinal tissue development of offspring after OVA stimulation. (A–E) Serum IgE, OVA-specific IgE/IgG1, IgM, and sIgA levels of offspring after OVA stimulation at PND 49. (F-K) Colonic Ki67, Muc2, and mRNA expression of tight junction proteins. *: P < 0.05, **: P < 0.01, ***: P < 0.001, ****: P < 0.0001, compared with Control. PND, postnatal day. n = 11/group.

      Response of fecal microbiota and alterations of SCFA to OVA stimulation of offspring

      After sensitization by OVA, the ACE, Chao1 index, and observed OTUs of the TMC3115 group tended to be higher than those of the Control group, while the Simpson index of the TMC3115 group was significantly lower ( Figure 6A ). Samples in the two groups were clearly separated into two clusters via PCoA ( Figure 6B ). The phyla Bacteroidota, Firmicutes, and genera Lactobacillus, Muribaculaceae, and Lachnospiraceae NK4A136 group predominated in both groups ( Figures 6C, E ). Compared with the Control group, the relative abundances of the phyla Actinobacteriota and Firmicutes, and the genera Blautia and unidentified Lachnospiriaceae in the TMC3115 group were significantly increased, while the abundance of the Lachnospiraceae NK4A136 group tended to be increased. However, the relative abundances of the phylum Bacteroidota and the genera Muribaculum, Muribaculuceae, and Odoribacter in the TMC3115 group were significantly decreased ( Figures 6D, F ). The fecal acetic, propionic, and butyric acid levels in the TMC3115 group were significantly higher than those in the Control group ( Figure 6G ). All the main findings of this manuscript have been summarized in Table 2 .

      Diversity and composition of fecal microbiota of offspring after OVA stimulation at PND 49. (A) Alterations of fecal microbial alpha diversity of offspring between groups. (B) PCoA analysis based on Bray-Curtis distance. (C, D) Fecal microbial community of offspring at the phylum level and significantly changed phyla between groups. (E, F) Fecal microbial community of offspring at the genus level and significantly changed genera between groups. (G) Fecal SCFA production of offspring after OVA stimulation at PND 49. *: P < 0.05, compared with Control. **: compared with Control, P <0.01. PND, postnatal day; AA, acetic acid; PA, propionic acid; BA, butyric acid. n = 6/group.

      Summary of main findings.

      Time points Main findings in TMC3115 group
      Dams ADD0 : vaginal Proteobacteria, Bifidobacterium
      : serum IgG1, IgG3 level;fecal sIgA level; fecal Proteobacteria; fecal AA level;vaginal alpha diversity; vaginal Firmicutes and Lactobacillus
      ADD21 : splenic IL-8, IL-10, and IL-17A mRNA expression;fecal Lactobacillus
      : simpson index of fecal microbiota;fecal AA and PA level;
      Pups PND0 : serum IgG, sIgA levelIgG level in stomach contents; Proteobacteria was predominate in stomach contents;small intestinal and colonic Proteobacteria and Acinetobacter
      : serum IgG3 level;small intestinal and colonic Firmicutes, Bacteroidota, Lactobacillus; alpha diversity and Bacteroidota and Lactobacillus in stomach contents
      PND7 : serum IgG3 level;colonic occludin mRNA expression
      : stomach contents IgG2a level;splenic TGF-β1 mRNA expression;alpha diversity of microbiota in stomach contents
      No significance: microbiota diversity and composition in stomach contents; small intestinal and colonic microbiota composition of intestinal contents
      PND14 : stomach contents IgG2a and IgM level
      No significance: microbiota diversity and composition in intestinal contents and stomach contents
      PND21 : colonic Ki67 and occludin mRNA expression; colonic depth;fecal Firmicutes and Lactobacillus
      : serum IgG, IgE level;fecal sIgA level; fecal Prevotellaceae UCG.00; fecal AA and PA level
      PND49 : serum IgE, IL-10, IL-17A level;splenic IL-10, IL-17A, and ROR-γt mRNA expression;fecal sIgA level; fecal Bacteroidota and Muribaculaceae
      : serum IgG, IgM, IgA, sIgA, IgG2a, IgG2b, and IgG3 level;fecal Firmicutes and Lachnospiraceae NK4A136 group; fecal PA level
      PND49 (OVA-stimulated) : serum IgM level;colonic Ki67, Muc2, ZO-1, claudin-1, claudin-2, and occludin mRNA expression;fecal Firmicutes, Lactobacillus and Lachnospiraceae NK4A136 group; fecal AA, BA and PA level
      : simpson index, fecal Bacteroidota
      No significance: serum IgE and OVA-specific IgE/IgG1

      increased indicators in TMC3115 group when compared with the Control group; decreased indicators in TMC3115 group when compared with the Control group. Negative results were not totally shown in this table.

      Discussion

      Pregnancy has an important effect on the gut microbiota composition. During this period, the structure of the gut microbiota is quite different from that found in non-pregnant individuals. There is a decline in diversity and the amount of butyric acid producing bacteria, and an increase in the abundance of Proteobacteria and Actinobacteria, as adaptations to the physiological pro-inflammatory response occurring during pregnancy (Koren et al., 2012). In the present study, gestational TMC3115 treatment did not alter the diversity of maternal gut microbiota, and the microbial composition remained relatively stable. However, gestational TMC3115 treatment reduced the levels of maternal SCFA, even when the treatment was discontinued for 21 days. SCFA have been shown to modify immune systems. A significant increase in the levels of mRNA for splenic cytokines after gestational TMC3115 treatment indicated that the immune function of mothers was altered to some extent. In this study, alteration of the maternal gut microbiota by gestational TMC3115 treatment was not apparent, while there may be regulation of the mother’s immune function through reduced SCFA production.

      We observed changes in the vaginal microbiota after gestational TMC3115 administration. The vaginal microbiota has been shown to be dominated by Lactobacillus, which could affect the composition of the neonatal gut microbiota (Greenbaum et al., 2019). The vaginal microbiota was markedly changed, with significantly decreased alpha diversity and abundance of Firmicutes and Lactobacillus, and significantly increased abundance of Proteobacteria; these changes in microbial composition were also observed in the gut microbiota of neonates. Gestational administration of TMC3115 significantly increased the relative abundance of vaginal Bifidobacterium, which was not found in the gut microbiota of neonates, indicating the TMC3115 might promote the vertical transmission of bifidobacteria from mother’s intestine to vagina as the evolutionary trait of bifidobacteria and the low diversity of vaginal microbiota and the low pH value within vagina (Wang et al., 2020; Stuivenberg et al., 2022). These results indicated that gestational TMC3115 treatment could significantly alter the microbiota of the mothers’ vaginas and the pups’ intestines.

      The maternal gut microbiota is also important in the composition of the breast milk microbiota and the gut microbiota of the offspring (Perez et al., 2007; de Andrés et al., 2017). In this study, the gut and stomach contents microbiota of pups at PND 0 were the most altered by gestational TMC3115 treatment, and were comparable with those at PND 7 and PND 14. At PND 0, the abundance of Proteobacteria was significantly increased and that of Lactobacillus and Firmicutes significantly decreased, in the vagina, stomach contents, and small intestinal and colonic contents, whereas the converse was found in the maternal gut microbiota at the same time point. These results were consistent with our previous birth cohort study (Shen et al., 2019); indicating that the “window of opportunity” period for the construction of the neonatal gut microbiota was as early as the day of birth.

      Studies have suggested that the “immune memories” produced by maternal events during pregnancy can have a sustained effect on the development of the offspring’s immune system, thereby assisting in the prevention of the development of allergic diseases (Jenmalm, 2017). Several of these effects depend on maternal antibodies, which may retain microbial-related immune molecules, and are passed to offspring during pregnancy and in breast milk (Vono et al., 2019; Zheng et al., 2020). We found that IgG was spontaneously and significantly increased in the stomach contents (a proxy of breast milk) and serum of neonates. IgG is the only antibody that can cross the placental barrier from mother to offspring. Therefore, it is speculated that the ingestion of exogenous microorganisms during pregnancy, such as the selective probiotic strain TMC3115, may induce the mother to produce specific antibodies and B cells with immune memory, and other microbe-related immune molecules. These can then enter the offspring via the placenta and breast milk to induce the offspring to form an immune tolerance to symbiotic bacteria and exogenous microorganisms, and to promote the development of the immune system and gut microbiota.

      Weaning (PND 21) was an important turning point for the gut microbiota and host immune and intestinal development. Al Nabhani et al. found that because of continuous microbial and food antigen stimulation during weaning, changes in the gut microbiota and metabolic products such as SCFA can cause a strong immune response; a “weaning reaction” (Al Nabhani et al., 2019). The weaning reaction can be considered as an amplified response of the immune interaction between the microbiota and the host, that is necessary for the formation of tolerance to immune-related diseases in adulthood. The lactation period is also considered to be a key period in the regulation of the gut microbiota (Ronan et al., 2021). In this study, the abundance of Lactobacillus was significantly increased both in maternal and offspring gut microbiota at weaning. The crypt depth, colonic epithelial cell proliferation, and expression of tight junction proteins of offspring were significantly increased at weaning, while the levels of IgE were significantly decreased after gestational TMC3115 treatment. The intestine, as the habitat of the gut microbiota and the largest immune tissue in the human body, plays a vital role in microbiota-host immunity interactions (Cheng et al., 2017). IgE is one of the important foundations and biomarkers for the diagnosis of allergic diseases (Owen, 2007), and an increase in IgE can reflect the body’s susceptibility to IgE-mediated allergic diseases, the main category of allergic diseases, to a certain extent (Sohn et al., 2005). Therefore, these results indicated that TMC3115 exposure during pregnancy could promote the development of intestinal tissue and enhance the intestinal barrier function of offspring. These changes may regulate the susceptibility of offspring to IgE-mediated allergic diseases. This effect does not appear in the neonatal period when the immune system is not fully developed, suggesting that it may be related to the changes in intestinal microbes during weaning and the corresponding weaning reaction.

      After weaning, the gut microbiota and immune system of offspring continuously changed during puberty (PND 49), although the effects on intestinal development were not persistent. Maternal gestational TMC3115 treatment significantly enhanced the mucosal immunity and ability to regulate inflammation, as evidenced by significantly increased levels of fecal sIgA and serum IL-10 and IL-17A, with dynamic changes in serum immunoglobulin. TMC3115 treatment significantly increased the abundance of Bacteroidota and Muribaculaceae, whereas those of Firmicutes and Lachnospiraceae NK4A136 group, and levels of propionic acid, all decreased. Most Bacteroidota and Firmicutes bacteria, including Muribaculaceae and Lachnospiraceae NK4A136, are SCFA producers (Koh et al., 2016). A recent study indicated that Muribaculaceae were a key taxon responsive to 2-O-β-d-glucopyranosyl-l-ascorbic acid, which can exert an immunomodulatory effect (Huang et al., 2020). The production of acetic acid and alterations found in immune systems may be induced by modifications of the gut microbiota. These results suggested that maternal events inside and outside the uterus, especially those affecting the gut microbiota and its metabolites, may have a remodeling effect on the intestines, microbiota, and immune system of the developing fetus, and continue until birth, with long-term effects.

      To further determine whether maternal TMC3115 treatment could affect the susceptibility of offspring to IgE-mediated allergic diseases, and to investigate the underlying mechanisms, an OVA-stimulated model was used, involving offspring from PND 21–PND 49. In this study, the differences in levels of serum IgE and OVA-specific IgE/IgG1 between groups were not significant, indicating that maternal TMC3115 treatment might not affect the susceptibility of offspring to IgE-mediated allergic diseases. However, maternal TMC3115 treatment significantly enhanced the primary immune response to antigens, as shown by the significantly increased level of serum IgM. Similarly, RCT studies have shown that probiotics as adjuvants have good prospects for application in the oral immunotherapy of food allergies, such as those for peanut, egg, and milk protein, with negative results in the levels of total serum IgE (Kim et al., 2010; Tang et al., 2015). The purpose of these applications is to quickly induce immune tolerance to allergens, and to avoid the possible side effects of simple oral food antigen therapy (Loh and Tang, 2018). Therefore, it is speculated that the administration of oral probiotics, such as TMC3115, during pregnancy may induce an immune tolerance to food allergens in the offspring, resulting in insensitivity to the IgE response.

      In the OVA-stimulated offspring, which were born from maternal TMC3115-treated dams, intestinal epithelial tissue development, mucin secretion, and intestinal barrier function were significantly enhanced, and the levels of SCFA and abundance of the SCFA-producing bacteria Lactobacillus and Lachnospiraceae NK4A136 group, were also increased, a finding which is consistent with our previous study, in which neonatal TMC3115 treatment from birth to weaning significantly decreased the susceptibility to IgE-mediated allergic diseases by regulating the gut microbiota and SCFA production (Cheng et al., 2019). SCFA can be used as an energy source for intestinal epithelial cells, to promote the development of intestinal tissues and enhance the intestinal barrier function. SCFA can also interact with G protein-coupled receptors on the surface of immune cells receptors and bind or inhibit the expression of histone deacetylases, to exert their immunomodulatory effects (Koh et al., 2016). A high dietary fiber maternal diet or acetic acid supplementation during pregnancy has been found to reduce the levels of serum cytokines and IgE and lung inflammatory cell infiltration in allergic airway reactions in adult offspring (Thorburn et al., 2015). Kimura et al. further found that maternally derived SCFA produced by a high dietary fiber diet during pregnancy can regulate the development of the intestinal tract and islets of the offspring during the embryonic period, through the maternal gut microbe-SCFA-embryo GPR41/GPR43 axis, to protect the offspring from metabolic diseases such as obesity (Kimura et al., 2020). Therefore, supplementation of selective probiotic strains such as TMC3115 during pregnancy may improve the level of SCFA in offspring in a manner similar to that of high dietary fiber diets, which may enhance the intestinal barrier function and the immune response ability of allergens.

      During the long-term co-evolution with the host, bifidobacteria has developed many unique physiological characteristics that are compatible with the host, such as decomposition of HMOs and tolerance to lysozyme in breast milk (Wong et al., 2020). Ecological studies have shown that vertical transmission from mother to offspring is a common ecological feature of bifidobacteria, reflecting the clear evolutionary relationship between Bifidobacterium species present in both the mother and offspring (Moeller et al., 2016). A number of population studies have also found that bifidobacteria can be passed from the mother’s vagina, gastrointestinal tract, breast milk, placenta, and amniotic fluid to infants, indicating that the mother is an important source of bifidobacteria found in the infant’s intestines, and that the vertical transmission of bifidobacteria from mother to infant is essential for the normal construction of infant gut microbiota (Wong et al., 2020; Wang et al., 2020). Furthermore, studies have shown that in addition to bifidobacteria, other members of the gut microbiota, such as the certain Streptococcus, Lactobacillus, and Lactococcus specices, may also be transferred from the mother to the infant’s intestines directly or to the breast milk, and then colonized through vertical transmission, thereby affecting the infant’s gut microbiota and immune system development (Perez et al., 2007). In light of this, we inferred that supplementation with TMC3115 during pregnancy can promote the vertical transmission of bifidobacteria and other gut microbiota from mother to infant, thereby promoting the immune development and reducing the risk of allergic diseases in offspring, although the specific involved molecule or cells need to be further clarified.

      In conclusion, the maternal gut microbiota, immune function, and intestinal tissue development were fundamentally stable after TMC3115 treatment, whereas the vaginal microbiota was dramatically altered, with a significant increase in alpha diversity and abundance of Bifidobacterium. The stomach contents from newborn offspring and the gut microbiota of neonates and weanlings were most changed by maternal TMC3115 treatment, suggesting that these two time points were the important “window of opportunity” for neonatal gut microbiota construction. Synchronous changes in the intestinal, vaginal, and stomach contents (a proxy for breast milk) microbiota were found both in mothers and offspring, involving Proteobacteria and Bifidobacterium. This observation suggests that the microbiota of maternal gut or breast milk may have a profound modulatory effect on the development of the immune system, intestinal tissue, and gut microbiota composition of offspring. Maternal TMC3115 treatment may induce an immune tolerance to OVA stimulation in offspring, and enhance intestinal tissue development, barrier function, and primary immune response to food allergens. These changes may be related to the significant increases in the relative abundances of Lactobacillus and Lachnospiraceae NK4A136 group, and in fecal SCFA production. Further research should focus on the role of signaling molecules and potential mechanisms of gut microbiota and their metabolites such as SCFA, that protect the body from immune diseases.

      This study has three limitations: ① although the stomach contents of offspring was considered to be a proxy for breast milk, microbiota found in the pups’ stomach contents in our present study might be not fully representative of the microbes in the mother’s breast milk, because the microbiota detected in the pups’ stomach contents might contain the microbes from the pups’ stomach, and the skin microbiota around the nipples or even fecal microbiota. ② Several studies have used feces as the sample origin when detecting gut microbiota, and the fecal microbiota has been considered as the best representative of the gut microbiota. However, in this study, we failed to collect the feces of pups at PND 0, 7, and 14. Hence, we used the intestinal contents as an proxy for feces, although the intestinal contents might contain the microbes resident in the intestinal mucosa, not just the microbes found in feces, making it different from the fecal microbiota of pups at PND 21 and 49. More appropriate methods for sampling the breast milk and feces of young pups are needed to draw a more powerful conclusion. ③ The IgE-mediated allergic disease animal model used in this present study was not a strict allergic diseases animal model, because no allergic symptoms, such as asthma or atopic dermatitis, were observed. The present model was used to evaluate the susceptibility of animals to IgE-mediated allergic diseases, because the main indicators were serum IgE, OVA-specific IgE, and other immune-related indexes, suggesting that considerable further research is needed for pre-clinical studies to be translated to clinical application. Further studies focusing on the preventive/alleviating effects of maternal TMC3115 usage on the offspring’s allergic diseases are needed.

      Data availability statement

      The data presented in the study are deposited in the NCBI repository, accession number: PRJNA774623. (https://dataview.ncbi.nlm.nih.gov/object/PRJNA774623?archive=sra).

      Ethics statement

      The animal study was reviewed and approved by the animal experiment facility and animals used for the present study were officially approved by the Experimental Animal Management Committee of the Sichuan Government. Experimental protocols were approved by the West China School of Public Health Medical Ethics Committee of Sichuan University (Approval number: SYXK2018-011).

      Author contributions

      RC, XS and FH designed this study; RC, YZ and YY conducted the experiment; JL and YW analyzed the data; LR provided the probiotic powder; RC wrote the original manuscript; RC, XS and FH revised the manuscript. All authors contributed to the article and approved the submitted version.

      Funding

      This work was supported by the National Natural Science Foundation of China (Grant number: 81973042) and National Science Foundation for Young Scientists of China (Grant number: 82003453) and China Postdoctoral Science Foundation (Grant number:2022M712228).

      Acknowledgments

      The authors would like to thank to Chengdu Basebiotech Co., Ltd. for providing assistance on bioinformatics analysis and Enago (http://www.enago.jp) for the English language review. We also appreciate the support of Public health and Preventive Medicine Provincial Experiment Teaching Center at Sichuan University and Food Safety Monitoring and Risk Assessment Key Laboratory of Sichuan Province.

      Conflict of interest

      LR is an employee of Hebei Inatural Bio-tech.

      The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.

      The reviewer RH declared a shared affiliation with the authors to the handling editor at the time of review.

      Publisher’s note

      All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

      Supplementary material

      The Supplementary Material for this article can be found online at: /articles/10.3389/fcimb.2022.1045109/full#supplementary-material

      References Al Nabhani Z. Dulauroy S. Marques R. Cousu C. Al Bounny S. Déjardin F. . (2019). A weaning reaction to microbiota is required for resistance to immunopathologies in the adult. Immunity 50 (5), 12761288.e1275. doi: 10.1016/j.immuni.2019.02.014 Amalia N. Orchard D. Francis K. L. King E. (2020). Systematic review and meta-analysis on the use of probiotic supplementation in pregnant mother, breastfeeding mother and infant for the prevention of atopic dermatitis in children. Australas. J. Dermatol. 61 (2), e158e173. doi: 10.1111/ajd.13186 Arrieta M. C. Stiemsma L. T. Amenyogbe N. Brown E. M. Finlay B. (2014). The intestinal microbiome in early life: health and disease. Front. Immunol. 5. doi: 10.3389/fimmu.2014.00427 Cheng R. Guo J. Pu F. Wan C. Shi L. Li H. . (2019). Loading ceftriaxone, vancomycin, and bifidobacteria bifidum TMC3115 to neonatal mice could differently and consequently affect intestinal microbiota and immunity in adulthood. Sci. Rep. 9 (1), 3254. doi: 10.1038/s41598-018-35737-1 Cheng R. Guo J. Zhang Y. Cheng G. Qian W. Wan C. . (2021). Impacts of ceftriaxone exposure during pregnancy on maternal gut and placental microbiota and its influence on maternal and offspring immunity in mice. Exp. Anim 70 (2), 203217. doi: 10.1538/expanim.20-0114 Cheng R. Liang H. Zhang Y. Guo J. Miao Z. Shen X. . (2020). Contributions of lactobacillus plantarum PC170 administration on the recovery of gut microbiota after short-term ceftriaxone exposure in mice. Benef. Microbes 11 (5), 489509. doi: 10.3920/bm2019.0191 Cheng R. Y. Li M. Li S. S. He M. Yu X. H. Shi L. . (2017). Vancomycin and ceftriaxone can damage intestinal microbiota and affect the development of the intestinal tract and immune system to different degrees in neonatal mice. Pathog. Dis. 75 (8):ftx104. doi: 10.1093/femspd/ftx104 Collado M. C. Rautava S. Aakko J. Isolauri E. Salminen S. (2016). Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci. Rep. 6, 23129. doi: 10.1038/srep23129 de Andrés J. Jiménez E. Chico-Calero I. Fresno M. Fernández L. Rodríguez J. M. (2017). Physiological translocation of lactic acid bacteria during pregnancy contributes to the composition of the milk microbiota in mice. Nutrients 10 (1), 14. doi: 10.3390/nu10010014 Gensollen T. Blumberg R. S. (2017). Correlation between early-life regulation of the immune system by microbiota and allergy development. J. Allergy Clin. Immunol. 139 (4), 10841091. doi: 10.1016/j.jaci.2017.02.011 Gomez de Agüero M. Ganal-Vonarburg S. C. Fuhrer T. Rupp S. Uchimura Y. Li H. . (2016). The maternal microbiota drives early postnatal innate immune development. Science 351 (6279), 12961302. doi: 10.1126/science.aad2571 Gotoh A. Katoh T. Sakanaka M. Ling Y. Yamada C. Asakuma S. . (2018). Sharing of human milk oligosaccharides degradants within bifidobacterial communities in faecal cultures supplemented with bifidobacterium bifidum. Sci. Rep. 8 (1), 13958. doi: 10.1038/s41598-018-32080-3 Greenbaum S. Greenbaum G. Moran-Gilad J. Weintraub A. Y. (2019). Ecological dynamics of the vaginal microbiome in relation to health and disease. Am. J. Obstet. Gynecol. 220 (4), 324335. doi: 10.1016/j.ajog.2018.11.1089 He F. Ouwehand A. C. Isolauri E. Hashimoto H. Benno Y. Salminen S. (2001). Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol. Med. Microbiol. 30 (1), 4347. doi: 10.1111/j.1574-695X.2001.tb01548.x Huang K. Yan Y. Chen D. Zhao Y. Dong W. Zeng X. . (2020). Ascorbic acid derivative 2-O-β-d-Glucopyranosyl-l-Ascorbic acid from the fruit of lycium barbarum modulates microbiota in the small intestine and colon and exerts an immunomodulatory effect on cyclophosphamide-treated BALB/c mice. J. Agric. Food Chem. 68 (40), 1112811143. doi: 10.1021/acs.jafc.0c04253 Jenmalm M. C. (2017). The mother-offspring dyad: microbial transmission, immune interactions and allergy development. J. Intern. Med. 282 (6), 484495. doi: 10.1111/joim.12652 Jing W. Liu Q. Wang W. (2020). Bifidobacterium bifidum TMC3115 ameliorates milk protein allergy in by affecting gut microbiota: A randomized double-blind control trial. J. Food Biochem. 44 (11), e13489. doi: 10.1111/jfbc.13489 Kim J. Y. Kwon J. H. Ahn S. H. Lee S. I. Han Y. S. Choi Y. O. . (2010). Effect of probiotic mix (Bifidobacterium bifidum, bifidobacterium lactis, lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr. Allergy Immunol. 21 (2 Pt 2), e386e393. doi: 10.1111/j.1399-3038.2009.00958.x Kimura I. Miyamoto J. Ohue-Kitano R. Watanabe K. Yamada T. Onuki M. . (2020). Maternal gut microbiota in pregnancy influences offspring metabolic phenotype in mice. Science 367 (6481), eaaw8429. doi: 10.1126/science.aaw8429 Koh A. De Vadder F. Kovatcheva-Datchary P. Bäckhed F. (2016). From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell 165 (6), 13321345. doi: 10.1016/j.cell.2016.05.041 Koren O. Goodrich J. K. Cullender T. C. Spor A. Laitinen K. Bäckhed H. K. . (2012). Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 150 (3), 470480. doi: 10.1016/j.cell.2012.07.008 Li L. Han Z. Niu X. Zhang G. Jia Y. Zhang S. . (2019). Probiotic supplementation for prevention of atopic dermatitis in infants and children: A systematic review and meta-analysis. Am. J. Clin. Dermatol. 20 (3), 367377. doi: 10.1007/s40257-018-0404-3 Loh W. Tang M. (2018). Adjuvant therapies in food immunotherapy. Immunol. Allergy Clin. North Am. 38 (1), 89101. doi: 10.1016/j.iac.2017.09.008 Moeller A. H. Caro-Quintero A. Mjungu D. Georgiev A. V. Lonsdorf E. V. Muller M. N. . (2016). Cospeciation of gut microbiota with hominids. Science 353 (6297), 380382. doi: 10.1126/science.aaf3951 Nyangahu D. D. Lennard K. S. Brown B. P. Darby M. G. Wendoh J. M. Havyarimana E. . (2018). Disruption of maternal gut microbiota during gestation alters offspring microbiota and immunity. Microbiome 6 (1), 124. doi: 10.1186/s40168-018-0511-7 Owen C. E. (2007). Immunoglobulin e: role in asthma and allergic disease: lessons from the clinic. Pharmacol. Ther. 113 (1), 121133. doi: 10.1016/j.pharmthera.2006.07.003 Perez P. F. Doré J. Leclerc M. Levenez F. Benyacoub J. Serrant P. . (2007). Bacterial imprinting of the neonatal immune system: lessons from maternal cells? Pediatrics 119 (3), e724e732. doi: 10.1542/peds.2006-1649 Platts-Mills T. A. (2015). The allergy epidemics: 1870-2010. J. Allergy Clin. Immunol. 136 (1), 313. doi: 10.1016/j.jaci.2015.03.048 Ronan V. Yeasin R. Claud E. C. (2021). Childhood development and the microbiome: The intestinal microbiota in maintenance of health and development of disease during childhood development Gastroenterology 160 (2), 495506. doi: 10.1053/j.gastro.2020.08.065 Shao Y. Forster S. C. Tsaliki E. Vervier K. Strang A. Simpson N. . (2019). Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature 574 (7776), 117121. doi: 10.1038/s41586-019-1560-1 Shen X. Wang M. Zhang X. He M. Li M. Cheng G. . (2019). Dynamic construction of gut microbiota may influence allergic diseases of infants in southwest China. BMC Microbiol. 19 (1), 123. doi: 10.1186/s12866-019-1489-4 Sohn M. H. Lee S. Y. Lee K. E. Kim K. E. (2005). Comparison of VIDAS stallertest and pharmacia CAP assays for detection of specific IgE antibodies in allergic children. Ann. Clin. Lab. Sci. 35 (3), 318322. Strachan D. P. (1989). Hay fever, hygiene, and household size. Bmj 299 (6710), 12591260. doi: 10.1136/bmj.299.6710.1259 Stuivenberg G. A. Burton J. P. Bron P. A. Reid G. (2022). Why are bifidobacteria important for infants? Microorganisms 10 (2), 278. doi: 10.3390/microorganisms10020278 Tang M. L. Ponsonby A. L. Orsini F. Tey D. Robinson M. Su E. L. . (2015). Administration of a probiotic with peanut oral immunotherapy: A randomized trial. J. Allergy Clin. Immunol. 135 (3), 737744.e738. doi: 10.1016/j.jaci.2014.11.034 Thorburn A. N. McKenzie C. I. Shen S. Stanley D. Macia L. Mason L. J. . (2015). Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat. Commun. 6, 7320. doi: 10.1038/ncomms8320 Vono M. Eberhardt C. S. Auderset F. Mastelic-Gavillet B. Lemeille S. Christensen D. . (2019). Maternal antibodies inhibit neonatal and infant responses to vaccination by shaping the early-life b cell repertoire within germinal centers. Cell Rep. 28 (7), 17731784.e1775. doi: 10.1016/j.celrep.2019.07.047 Wang S. Ryan C. A. Boyaval P. Dempsey E. M. Ross R. P. Stanton C. (2020). Maternal vertical transmission affecting early-life microbiota development. Trends Microbiol. 28 (1), 2845. doi: 10.1016/j.tim.2019.07.010 Wong C. B. Odamaki T. Xiao J. Z. (2020). Insights into the reason of human-residential bifidobacteria (HRB) being the natural inhabitants of the human gut and their potential health-promoting benefits. FEMS Microbiol. Rev. 44 (3), 369385. doi: 10.1093/femsre/fuaa010 Zheng W. Zhao W. Wu M. Song X. Caro F. Sun X. . (2020). Microbiota-targeted maternal antibodies protect neonates from enteric infection. Nature 577 (7791), 543548. doi: 10.1038/s41586-019-1898-4
      ‘Oh, my dear Thomas, you haven’t heard the terrible news then?’ she said. ‘I thought you would be sure to have seen it placarded somewhere. Alice went straight to her room, and I haven’t seen her since, though I repeatedly knocked at the door, which she has locked on the inside, and I’m sure it’s most unnatural of her not to let her own mother comfort her. It all happened in a moment: I have always said those great motor-cars shouldn’t be allowed to career about the streets, especially when they are all paved with cobbles as they are at Easton Haven, which are{331} so slippery when it’s wet. He slipped, and it went over him in a moment.’ My thanks were few and awkward, for there still hung to the missive a basting thread, and it was as warm as a nestling bird. I bent low--everybody was emotional in those days--kissed the fragrant thing, thrust it into my bosom, and blushed worse than Camille. "What, the Corner House victim? Is that really a fact?" "My dear child, I don't look upon it in that light at all. The child gave our picturesque friend a certain distinction--'My husband is dead, and this is my only child,' and all that sort of thing. It pays in society." leave them on the steps of a foundling asylum in order to insure [See larger version] Interoffice guff says you're planning definite moves on your own, J. O., and against some opposition. Is the Colonel so poor or so grasping—or what? Albert could not speak, for he felt as if his brains and teeth were rattling about inside his head. The rest of[Pg 188] the family hunched together by the door, the boys gaping idiotically, the girls in tears. "Now you're married." The host was called in, and unlocked a drawer in which they were deposited. The galleyman, with visible reluctance, arrayed himself in the garments, and he was observed to shudder more than once during the investiture of the dead man's apparel. HoME香京julia种子在线播放 ENTER NUMBET 0016www.hexlabs.com.cn
      jiahei.com.cn
      www.leevi.com.cn
      mczorz.com.cn
      hosegroup.com.cn
      www.l37.com.cn
      www.laimaiche.com.cn
      fjqrgp.com.cn
      nu1.com.cn
      tzrguo.com.cn
      处女被大鸡巴操 强奸乱伦小说图片 俄罗斯美女爱爱图 调教强奸学生 亚洲女的穴 夜来香图片大全 美女性强奸电影 手机版色中阁 男性人体艺术素描图 16p成人 欧美性爱360 电影区 亚洲电影 欧美电影 经典三级 偷拍自拍 动漫电影 乱伦电影 变态另类 全部电 类似狠狠鲁的网站 黑吊操白逼图片 韩国黄片种子下载 操逼逼逼逼逼 人妻 小说 p 偷拍10幼女自慰 极品淫水很多 黄色做i爱 日本女人人体电影快播看 大福国小 我爱肏屄美女 mmcrwcom 欧美多人性交图片 肥臀乱伦老头舔阴帝 d09a4343000019c5 西欧人体艺术b xxoo激情短片 未成年人的 插泰国人夭图片 第770弾み1 24p 日本美女性 交动态 eee色播 yantasythunder 操无毛少女屄 亚洲图片你懂的女人 鸡巴插姨娘 特级黄 色大片播 左耳影音先锋 冢本友希全集 日本人体艺术绿色 我爱被舔逼 内射 幼 美阴图 喷水妹子高潮迭起 和后妈 操逼 美女吞鸡巴 鸭个自慰 中国女裸名单 操逼肥臀出水换妻 色站裸体义术 中国行上的漏毛美女叫什么 亚洲妹性交图 欧美美女人裸体人艺照 成人色妹妹直播 WWW_JXCT_COM r日本女人性淫乱 大胆人艺体艺图片 女同接吻av 碰碰哥免费自拍打炮 艳舞写真duppid1 88电影街拍视频 日本自拍做爱qvod 实拍美女性爱组图 少女高清av 浙江真实乱伦迅雷 台湾luanlunxiaoshuo 洛克王国宠物排行榜 皇瑟电影yy频道大全 红孩儿连连看 阴毛摄影 大胆美女写真人体艺术摄影 和风骚三个媳妇在家做爱 性爱办公室高清 18p2p木耳 大波撸影音 大鸡巴插嫩穴小说 一剧不超两个黑人 阿姨诱惑我快播 幼香阁千叶县小学生 少女妇女被狗强奸 曰人体妹妹 十二岁性感幼女 超级乱伦qvod 97爱蜜桃ccc336 日本淫妇阴液 av海量资源999 凤凰影视成仁 辰溪四中艳照门照片 先锋模特裸体展示影片 成人片免费看 自拍百度云 肥白老妇女 女爱人体图片 妈妈一女穴 星野美夏 日本少女dachidu 妹子私处人体图片 yinmindahuitang 舔无毛逼影片快播 田莹疑的裸体照片 三级电影影音先锋02222 妻子被外国老头操 观月雏乃泥鳅 韩国成人偷拍自拍图片 强奸5一9岁幼女小说 汤姆影院av图片 妹妹人艺体图 美女大驱 和女友做爱图片自拍p 绫川まどか在线先锋 那么嫩的逼很少见了 小女孩做爱 处女好逼连连看图图 性感美女在家做爱 近距离抽插骚逼逼 黑屌肏金毛屄 日韩av美少女 看喝尿尿小姐日逼色色色网图片 欧美肛交新视频 美女吃逼逼 av30线上免费 伊人在线三级经典 新视觉影院t6090影院 最新淫色电影网址 天龙影院远古手机版 搞老太影院 插进美女的大屁股里 私人影院加盟费用 www258dd 求一部电影里面有一个二猛哥 深肛交 日本萌妹子人体艺术写真图片 插入屄眼 美女的木奶 中文字幕黄色网址影视先锋 九号女神裸 和骚人妻偷情 和潘晓婷做爱 国模大尺度蜜桃 欧美大逼50p 西西人体成人 李宗瑞继母做爱原图物处理 nianhuawang 男鸡巴的视屏 � 97免费色伦电影 好色网成人 大姨子先锋 淫荡巨乳美女教师妈妈 性nuexiaoshuo WWW36YYYCOM 长春继续给力进屋就操小女儿套干破内射对白淫荡 农夫激情社区 日韩无码bt 欧美美女手掰嫩穴图片 日本援交偷拍自拍 入侵者日本在线播放 亚洲白虎偷拍自拍 常州高见泽日屄 寂寞少妇自卫视频 人体露逼图片 多毛外国老太 变态乱轮手机在线 淫荡妈妈和儿子操逼 伦理片大奶少女 看片神器最新登入地址sqvheqi345com账号群 麻美学姐无头 圣诞老人射小妞和强奸小妞动话片 亚洲AV女老师 先锋影音欧美成人资源 33344iucoom zV天堂电影网 宾馆美女打炮视频 色五月丁香五月magnet 嫂子淫乱小说 张歆艺的老公 吃奶男人视频在线播放 欧美色图男女乱伦 avtt2014ccvom 性插色欲香影院 青青草撸死你青青草 99热久久第一时间 激情套图卡通动漫 幼女裸聊做爱口交 日本女人被强奸乱伦 草榴社区快播 2kkk正在播放兽骑 啊不要人家小穴都湿了 www猎奇影视 A片www245vvcomwwwchnrwhmhzcn 搜索宜春院av wwwsee78co 逼奶鸡巴插 好吊日AV在线视频19gancom 熟女伦乱图片小说 日本免费av无码片在线开苞 鲁大妈撸到爆 裸聊官网 德国熟女xxx 新不夜城论坛首页手机 女虐男网址 男女做爱视频华为网盘 激情午夜天亚洲色图 内裤哥mangent 吉沢明歩制服丝袜WWWHHH710COM 屌逼在线试看 人体艺体阿娇艳照 推荐一个可以免费看片的网站如果被QQ拦截请复制链接在其它浏览器打开xxxyyy5comintr2a2cb551573a2b2e 欧美360精品粉红鲍鱼 教师调教第一页 聚美屋精品图 中韩淫乱群交 俄罗斯撸撸片 把鸡巴插进小姨子的阴道 干干AV成人网 aolasoohpnbcn www84ytom 高清大量潮喷www27dyycom 宝贝开心成人 freefronvideos人母 嫩穴成人网gggg29com 逼着舅妈给我口交肛交彩漫画 欧美色色aV88wwwgangguanscom 老太太操逼自拍视频 777亚洲手机在线播放 有没有夫妻3p小说 色列漫画淫女 午间色站导航 欧美成人处女色大图 童颜巨乳亚洲综合 桃色性欲草 色眯眯射逼 无码中文字幕塞外青楼这是一个 狂日美女老师人妻 爱碰网官网 亚洲图片雅蠛蝶 快播35怎么搜片 2000XXXX电影 新谷露性家庭影院 深深候dvd播放 幼齿用英语怎么说 不雅伦理无需播放器 国外淫荡图片 国外网站幼幼嫩网址 成年人就去色色视频快播 我鲁日日鲁老老老我爱 caoshaonvbi 人体艺术avav 性感性色导航 韩国黄色哥来嫖网站 成人网站美逼 淫荡熟妇自拍 欧美色惰图片 北京空姐透明照 狼堡免费av视频 www776eom 亚洲无码av欧美天堂网男人天堂 欧美激情爆操 a片kk266co 色尼姑成人极速在线视频 国语家庭系列 蒋雯雯 越南伦理 色CC伦理影院手机版 99jbbcom 大鸡巴舅妈 国产偷拍自拍淫荡对话视频 少妇春梦射精 开心激动网 自拍偷牌成人 色桃隐 撸狗网性交视频 淫荡的三位老师 伦理电影wwwqiuxia6commqiuxia6com 怡春院分站 丝袜超短裙露脸迅雷下载 色制服电影院 97超碰好吊色男人 yy6080理论在线宅男日韩福利大全 大嫂丝袜 500人群交手机在线 5sav 偷拍熟女吧 口述我和妹妹的欲望 50p电脑版 wwwavtttcon 3p3com 伦理无码片在线看 欧美成人电影图片岛国性爱伦理电影 先锋影音AV成人欧美 我爱好色 淫电影网 WWW19MMCOM 玛丽罗斯3d同人动画h在线看 动漫女孩裸体 超级丝袜美腿乱伦 1919gogo欣赏 大色逼淫色 www就是撸 激情文学网好骚 A级黄片免费 xedd5com 国内的b是黑的 快播美国成年人片黄 av高跟丝袜视频 上原保奈美巨乳女教师在线观看 校园春色都市激情fefegancom 偷窥自拍XXOO 搜索看马操美女 人本女优视频 日日吧淫淫 人妻巨乳影院 美国女子性爱学校 大肥屁股重口味 啪啪啪啊啊啊不要 操碰 japanfreevideoshome国产 亚州淫荡老熟女人体 伦奸毛片免费在线看 天天影视se 樱桃做爱视频 亚卅av在线视频 x奸小说下载 亚洲色图图片在线 217av天堂网 东方在线撸撸-百度 幼幼丝袜集 灰姑娘的姐姐 青青草在线视频观看对华 86papa路con 亚洲1AV 综合图片2区亚洲 美国美女大逼电影 010插插av成人网站 www色comwww821kxwcom 播乐子成人网免费视频在线观看 大炮撸在线影院 ,www4KkKcom 野花鲁最近30部 wwwCC213wapwww2233ww2download 三客优最新地址 母亲让儿子爽的无码视频 全国黄色片子 欧美色图美国十次 超碰在线直播 性感妖娆操 亚洲肉感熟女色图 a片A毛片管看视频 8vaa褋芯屑 333kk 川岛和津实视频 在线母子乱伦对白 妹妹肥逼五月 亚洲美女自拍 老婆在我面前小说 韩国空姐堪比情趣内衣 干小姐综合 淫妻色五月 添骚穴 WM62COM 23456影视播放器 成人午夜剧场 尼姑福利网 AV区亚洲AV欧美AV512qucomwwwc5508com 经典欧美骚妇 震动棒露出 日韩丝袜美臀巨乳在线 av无限吧看 就去干少妇 色艺无间正面是哪集 校园春色我和老师做爱 漫画夜色 天海丽白色吊带 黄色淫荡性虐小说 午夜高清播放器 文20岁女性荫道口图片 热国产热无码热有码 2015小明发布看看算你色 百度云播影视 美女肏屄屄乱轮小说 家族舔阴AV影片 邪恶在线av有码 父女之交 关于处女破处的三级片 极品护士91在线 欧美虐待女人视频的网站 享受老太太的丝袜 aaazhibuo 8dfvodcom成人 真实自拍足交 群交男女猛插逼 妓女爱爱动态 lin35com是什么网站 abp159 亚洲色图偷拍自拍乱伦熟女抠逼自慰 朝国三级篇 淫三国幻想 免费的av小电影网站 日本阿v视频免费按摩师 av750c0m 黄色片操一下 巨乳少女车震在线观看 操逼 免费 囗述情感一乱伦岳母和女婿 WWW_FAMITSU_COM 偷拍中国少妇在公车被操视频 花也真衣论理电影 大鸡鸡插p洞 新片欧美十八岁美少 进击的巨人神thunderftp 西方美女15p 深圳哪里易找到老女人玩视频 在线成人有声小说 365rrr 女尿图片 我和淫荡的小姨做爱 � 做爱技术体照 淫妇性爱 大学生私拍b 第四射狠狠射小说 色中色成人av社区 和小姨子乱伦肛交 wwwppp62com 俄罗斯巨乳人体艺术 骚逼阿娇 汤芳人体图片大胆 大胆人体艺术bb私处 性感大胸骚货 哪个网站幼女的片多 日本美女本子把 色 五月天 婷婷 快播 美女 美穴艺术 色百合电影导航 大鸡巴用力 孙悟空操美少女战士 狠狠撸美女手掰穴图片 古代女子与兽类交 沙耶香套图 激情成人网区 暴风影音av播放 动漫女孩怎么插第3个 mmmpp44 黑木麻衣无码ed2k 淫荡学姐少妇 乱伦操少女屄 高中性爱故事 骚妹妹爱爱图网 韩国模特剪长发 大鸡巴把我逼日了 中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片 大胆女人下体艺术图片 789sss 影音先锋在线国内情侣野外性事自拍普通话对白 群撸图库 闪现君打阿乐 ady 小说 插入表妹嫩穴小说 推荐成人资源 网络播放器 成人台 149大胆人体艺术 大屌图片 骚美女成人av 春暖花开春色性吧 女亭婷五月 我上了同桌的姐姐 恋夜秀场主播自慰视频 yzppp 屄茎 操屄女图 美女鲍鱼大特写 淫乱的日本人妻山口玲子 偷拍射精图 性感美女人体艺木图片 种马小说完本 免费电影院 骑士福利导航导航网站 骚老婆足交 国产性爱一级电影 欧美免费成人花花性都 欧美大肥妞性爱视频 家庭乱伦网站快播 偷拍自拍国产毛片 金发美女也用大吊来开包 缔D杏那 yentiyishu人体艺术ytys WWWUUKKMCOM 女人露奶 � 苍井空露逼 老荡妇高跟丝袜足交 偷偷和女友的朋友做爱迅雷 做爱七十二尺 朱丹人体合成 麻腾由纪妃 帅哥撸播种子图 鸡巴插逼动态图片 羙国十次啦中文 WWW137AVCOM 神斗片欧美版华语 有气质女人人休艺术 由美老师放屁电影 欧美女人肉肏图片 白虎种子快播 国产自拍90后女孩 美女在床上疯狂嫩b 饭岛爱最后之作 幼幼强奸摸奶 色97成人动漫 两性性爱打鸡巴插逼 新视觉影院4080青苹果影院 嗯好爽插死我了 阴口艺术照 李宗瑞电影qvod38 爆操舅母 亚洲色图七七影院 被大鸡巴操菊花 怡红院肿么了 成人极品影院删除 欧美性爱大图色图强奸乱 欧美女子与狗随便性交 苍井空的bt种子无码 熟女乱伦长篇小说 大色虫 兽交幼女影音先锋播放 44aad be0ca93900121f9b 先锋天耗ばさ无码 欧毛毛女三级黄色片图 干女人黑木耳照 日本美女少妇嫩逼人体艺术 sesechangchang 色屄屄网 久久撸app下载 色图色噜 美女鸡巴大奶 好吊日在线视频在线观看 透明丝袜脚偷拍自拍 中山怡红院菜单 wcwwwcom下载 骑嫂子 亚洲大色妣 成人故事365ahnet 丝袜家庭教mp4 幼交肛交 妹妹撸撸大妈 日本毛爽 caoprom超碰在email 关于中国古代偷窥的黄片 第一会所老熟女下载 wwwhuangsecome 狼人干综合新地址HD播放 变态儿子强奸乱伦图 强奸电影名字 2wwwer37com 日本毛片基地一亚洲AVmzddcxcn 暗黑圣经仙桃影院 37tpcocn 持月真由xfplay 好吊日在线视频三级网 我爱背入李丽珍 电影师傅床戏在线观看 96插妹妹sexsex88com 豪放家庭在线播放 桃花宝典极夜著豆瓜网 安卓系统播放神器 美美网丝袜诱惑 人人干全免费视频xulawyercn av无插件一本道 全国色五月 操逼电影小说网 good在线wwwyuyuelvcom www18avmmd 撸波波影视无插件 伊人幼女成人电影 会看射的图片 小明插看看 全裸美女扒开粉嫩b 国人自拍性交网站 萝莉白丝足交本子 七草ちとせ巨乳视频 摇摇晃晃的成人电影 兰桂坊成社人区小说www68kqcom 舔阴论坛 久撸客一撸客色国内外成人激情在线 明星门 欧美大胆嫩肉穴爽大片 www牛逼插 性吧星云 少妇性奴的屁眼 人体艺术大胆mscbaidu1imgcn 最新久久色色成人版 l女同在线 小泽玛利亚高潮图片搜索 女性裸b图 肛交bt种子 最热门有声小说 人间添春色 春色猜谜字 樱井莉亚钢管舞视频 小泽玛利亚直美6p 能用的h网 还能看的h网 bl动漫h网 开心五月激 东京热401 男色女色第四色酒色网 怎么下载黄色小说 黄色小说小栽 和谐图城 乐乐影院 色哥导航 特色导航 依依社区 爱窝窝在线 色狼谷成人 91porn 包要你射电影 色色3A丝袜 丝袜妹妹淫网 爱色导航(荐) 好男人激情影院 坏哥哥 第七色 色久久 人格分裂 急先锋 撸撸射中文网 第一会所综合社区 91影院老师机 东方成人激情 怼莪影院吹潮 老鸭窝伊人无码不卡无码一本道 av女柳晶电影 91天生爱风流作品 深爱激情小说私房婷婷网 擼奶av 567pao 里番3d一家人野外 上原在线电影 水岛津实透明丝袜 1314酒色 网旧网俺也去 0855影院 在线无码私人影院 搜索 国产自拍 神马dy888午夜伦理达达兔 农民工黄晓婷 日韩裸体黑丝御姐 屈臣氏的燕窝面膜怎么样つぼみ晶エリーの早漏チ○ポ强化合宿 老熟女人性视频 影音先锋 三上悠亚ol 妹妹影院福利片 hhhhhhhhsxo 午夜天堂热的国产 强奸剧场 全裸香蕉视频无码 亚欧伦理视频 秋霞为什么给封了 日本在线视频空天使 日韩成人aⅴ在线 日本日屌日屄导航视频 在线福利视频 日本推油无码av magnet 在线免费视频 樱井梨吮东 日本一本道在线无码DVD 日本性感诱惑美女做爱阴道流水视频 日本一级av 汤姆avtom在线视频 台湾佬中文娱乐线20 阿v播播下载 橙色影院 奴隶少女护士cg视频 汤姆在线影院无码 偷拍宾馆 业面紧急生级访问 色和尚有线 厕所偷拍一族 av女l 公交色狼优酷视频 裸体视频AV 人与兽肉肉网 董美香ol 花井美纱链接 magnet 西瓜影音 亚洲 自拍 日韩女优欧美激情偷拍自拍 亚洲成年人免费视频 荷兰免费成人电影 深喉呕吐XXⅩX 操石榴在线视频 天天色成人免费视频 314hu四虎 涩久免费视频在线观看 成人电影迅雷下载 能看见整个奶子的香蕉影院 水菜丽百度影音 gwaz079百度云 噜死你们资源站 主播走光视频合集迅雷下载 thumbzilla jappen 精品Av 古川伊织star598在线 假面女皇vip在线视频播放 国产自拍迷情校园 啪啪啪公寓漫画 日本阿AV 黄色手机电影 欧美在线Av影院 华裔电击女神91在线 亚洲欧美专区 1日本1000部免费视频 开放90后 波多野结衣 东方 影院av 页面升级紧急访问每天正常更新 4438Xchengeren 老炮色 a k福利电影 色欲影视色天天视频 高老庄aV 259LUXU-683 magnet 手机在线电影 国产区 欧美激情人人操网 国产 偷拍 直播 日韩 国内外激情在线视频网给 站长统计一本道人妻 光棍影院被封 紫竹铃取汁 ftp 狂插空姐嫩 xfplay 丈夫面前 穿靴子伪街 XXOO视频在线免费 大香蕉道久在线播放 电棒漏电嗨过头 充气娃能看下毛和洞吗 夫妻牲交 福利云点墦 yukun瑟妃 疯狂交换女友 国产自拍26页 腐女资源 百度云 日本DVD高清无码视频 偷拍,自拍AV伦理电影 A片小视频福利站。 大奶肥婆自拍偷拍图片 交配伊甸园 超碰在线视频自拍偷拍国产 小热巴91大神 rctd 045 类似于A片 超美大奶大学生美女直播被男友操 男友问 你的衣服怎么脱掉的 亚洲女与黑人群交视频一 在线黄涩 木内美保步兵番号 鸡巴插入欧美美女的b舒服 激情在线国产自拍日韩欧美 国语福利小视频在线观看 作爱小视颍 潮喷合集丝袜无码mp4 做爱的无码高清视频 牛牛精品 伊aⅤ在线观看 savk12 哥哥搞在线播放 在线电一本道影 一级谍片 250pp亚洲情艺中心,88 欧美一本道九色在线一 wwwseavbacom色av吧 cos美女在线 欧美17,18ⅹⅹⅹ视频 自拍嫩逼 小电影在线观看网站 筱田优 贼 水电工 5358x视频 日本69式视频有码 b雪福利导航 韩国女主播19tvclub在线 操逼清晰视频 丝袜美女国产视频网址导航 水菜丽颜射房间 台湾妹中文娱乐网 风吟岛视频 口交 伦理 日本熟妇色五十路免费视频 A级片互舔 川村真矢Av在线观看 亚洲日韩av 色和尚国产自拍 sea8 mp4 aV天堂2018手机在线 免费版国产偷拍a在线播放 狠狠 婷婷 丁香 小视频福利在线观看平台 思妍白衣小仙女被邻居强上 萝莉自拍有水 4484新视觉 永久发布页 977成人影视在线观看 小清新影院在线观 小鸟酱后丝后入百度云 旋风魅影四级 香蕉影院小黄片免费看 性爱直播磁力链接 小骚逼第一色影院 性交流的视频 小雪小视频bd 小视频TV禁看视频 迷奸AV在线看 nba直播 任你在干线 汤姆影院在线视频国产 624u在线播放 成人 一级a做爰片就在线看狐狸视频 小香蕉AV视频 www182、com 腿模简小育 学生做爱视频 秘密搜查官 快播 成人福利网午夜 一级黄色夫妻录像片 直接看的gav久久播放器 国产自拍400首页 sm老爹影院 谁知道隔壁老王网址在线 综合网 123西瓜影音 米奇丁香 人人澡人人漠大学生 色久悠 夜色视频你今天寂寞了吗? 菲菲影视城美国 被抄的影院 变态另类 欧美 成人 国产偷拍自拍在线小说 不用下载安装就能看的吃男人鸡巴视频 插屄视频 大贯杏里播放 wwwhhh50 233若菜奈央 伦理片天海翼秘密搜查官 大香蕉在线万色屋视频 那种漫画小说你懂的 祥仔电影合集一区 那里可以看澳门皇冠酒店a片 色自啪 亚洲aV电影天堂 谷露影院ar toupaizaixian sexbj。com 毕业生 zaixian mianfei 朝桐光视频 成人短视频在线直接观看 陈美霖 沈阳音乐学院 导航女 www26yjjcom 1大尺度视频 开平虐女视频 菅野雪松协和影视在线视频 华人play在线视频bbb 鸡吧操屄视频 多啪啪免费视频 悠草影院 金兰策划网 (969) 橘佑金短视频 国内一极刺激自拍片 日本制服番号大全magnet 成人动漫母系 电脑怎么清理内存 黄色福利1000 dy88午夜 偷拍中学生洗澡磁力链接 花椒相机福利美女视频 站长推荐磁力下载 mp4 三洞轮流插视频 玉兔miki热舞视频 夜生活小视频 爆乳人妖小视频 国内网红主播自拍福利迅雷下载 不用app的裸裸体美女操逼视频 变态SM影片在线观看 草溜影院元气吧 - 百度 - 百度 波推全套视频 国产双飞集合ftp 日本在线AV网 笔国毛片 神马影院女主播是我的邻居 影音资源 激情乱伦电影 799pao 亚洲第一色第一影院 av视频大香蕉 老梁故事汇希斯莱杰 水中人体磁力链接 下载 大香蕉黄片免费看 济南谭崔 避开屏蔽的岛a片 草破福利 要看大鸡巴操小骚逼的人的视频 黑丝少妇影音先锋 欧美巨乳熟女磁力链接 美国黄网站色大全 伦蕉在线久播 极品女厕沟 激情五月bd韩国电影 混血美女自摸和男友激情啪啪自拍诱人呻吟福利视频 人人摸人人妻做人人看 44kknn 娸娸原网 伊人欧美 恋夜影院视频列表安卓青青 57k影院 如果电话亭 avi 插爆骚女精品自拍 青青草在线免费视频1769TV 令人惹火的邻家美眉 影音先锋 真人妹子被捅动态图 男人女人做完爱视频15 表姐合租两人共处一室晚上她竟爬上了我的床 性爱教学视频 北条麻妃bd在线播放版 国产老师和师生 magnet wwwcctv1024 女神自慰 ftp 女同性恋做激情视频 欧美大胆露阴视频 欧美无码影视 好女色在线观看 后入肥臀18p 百度影视屏福利 厕所超碰视频 强奸mp magnet 欧美妹aⅴ免费线上看 2016年妞干网视频 5手机在线福利 超在线最视频 800av:cOm magnet 欧美性爱免播放器在线播放 91大款肥汤的性感美乳90后邻家美眉趴着窗台后入啪啪 秋霞日本毛片网站 cheng ren 在线视频 上原亚衣肛门无码解禁影音先锋 美脚家庭教师在线播放 尤酷伦理片 熟女性生活视频在线观看 欧美av在线播放喷潮 194avav 凤凰AV成人 - 百度 kbb9999 AV片AV在线AV无码 爱爱视频高清免费观看 黄色男女操b视频 观看 18AV清纯视频在线播放平台 成人性爱视频久久操 女性真人生殖系统双性人视频 下身插入b射精视频 明星潜规测视频 mp4 免賛a片直播绪 国内 自己 偷拍 在线 国内真实偷拍 手机在线 国产主播户外勾在线 三桥杏奈高清无码迅雷下载 2五福电影院凸凹频频 男主拿鱼打女主,高宝宝 色哥午夜影院 川村まや痴汉 草溜影院费全过程免费 淫小弟影院在线视频 laohantuiche 啪啪啪喷潮XXOO视频 青娱乐成人国产 蓝沢润 一本道 亚洲青涩中文欧美 神马影院线理论 米娅卡莉法的av 在线福利65535 欧美粉色在线 欧美性受群交视频1在线播放 极品喷奶熟妇在线播放 变态另类无码福利影院92 天津小姐被偷拍 磁力下载 台湾三级电髟全部 丝袜美腿偷拍自拍 偷拍女生性行为图 妻子的乱伦 白虎少妇 肏婶骚屄 外国大妈会阴照片 美少女操屄图片 妹妹自慰11p 操老熟女的b 361美女人体 360电影院樱桃 爱色妹妹亚洲色图 性交卖淫姿势高清图片一级 欧美一黑对二白 大色网无毛一线天 射小妹网站 寂寞穴 西西人体模特苍井空 操的大白逼吧 骚穴让我操 拉好友干女朋友3p